Publications

Publications

Filter Results: (117) Arrow Down

Show Results For

← Page 6 of 117 Results
Sort by

Are you looking for?

→Search All HBS Web
  • 18 Jun 2001
  • Research & Ideas

When In-House Research Isn’t Enough

owe their life's blood to PARC—Adobe, SynOptics, VLSI, and 3Com, for example—together recorded a market value last year five or six times greater than that of mother Xerox. "By focusing too narrowly on its core, vertically-integrated... View Details
Keywords: by Jim Aisner
  • 26 Sep 2017
  • First Look

First Look at New Research and Ideas, September 26, 2017

Business School Case 817-060 RubiconMD No abstract available. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/817060-PDF-ENG Harvard Business School Case 517-127 Theranos: Small Volume Blood Testing (A) No abstract available.... View Details
Keywords: Sean Silverthorne
  • 01 Nov 2012
  • Research & Ideas

Book Excerpt: Judgment Calls

blood and hustle might come crashing down was a nontrivial possibility. But so was an increase in revenue that would elevate the company to a whole new league of wealth and market share. Founder and CEO Dal LaMagna chafed at the potential... View Details
Keywords: by Thomas H. Davenport & Brook Manville; Consumer Products
  • 08 Nov 2010
  • Research & Ideas

How to Fix a Broken Marketplace

give a kidney to person B, but their blood types don't match. Meanwhile, person C wants to give a kidney to person D, but their immune systems are incompatible. However, person A happens to be compatible with person D, and person C is... View Details
Keywords: by Carmen Nobel; Health
  • 24 Sep 2007
  • Research & Ideas

The FDA: What Will the Next 100 Years Bring?

state after an outbreak of illness. Approved the first generic versions of Coreg, a widely used medication for high blood pressure and chronic heart failure. Proposed new standards for formulating, testing, and labeling sunscreen drug... View Details
Keywords: by Sean Silverthorne; Biotechnology; Consumer Products; Food & Beverage; Health
  • 08 Aug 2017
  • First Look

First Look at Research and Ideas, August 8, 2017

of unit culture was also associated with a significantly higher risk of prolonged length of stay (RR 4.13, 95% CI 1.98–8.64), postpartum hemorrhage (RR 2.57, 95% CI 1.58–4.18), and blood transfusion (RR 1.87, 95% CI 1.12–3.13). Proactive... View Details
Keywords: Sean Silverthorne
  • 26 May 2015
  • First Look

First Look: May 26

2015, Chris Godfrey, founder and CEO of Bloodbuy, has to consider the best path to growth for his young company, which is attempting to disrupt the blood donation industry. Purchase this case:... View Details
Keywords: Sean Silverthorne
  • 29 Oct 2013
  • First Look

First Look: October 29

scheme, more extensive than any previously revealed in professional sports history." Until that moment with Oprah, Armstrong had consistently and strenuously denied using performance enhancing drugs (PEDs), blood transfusions, or... View Details
Keywords: Sean Silverthorne
  • 10 Jan 2017
  • First Look

First Look at New Research: January 10, 2017

Medicine program allows patients to record their blood pressure at home and share readings with their medical providers in real time. A year and a half after launching the program, the health system’s internal startup, innovationOchsner,... View Details
Keywords: Sean Silverthorne
  • 23 May 2019
  • Book

These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems

with multiple myeloma, a rare and incurable blood cancer, Kathy Giusti cofounded the Multiple Myeloma Research Foundation, which has helped thousands of other patients with the cancer and has accelerated drug discovery and development for... View Details
Keywords: by Dina Gerdeman; Green Technology
  • 12 May 2009
  • First Look

First Look: May 12, 2009

Management, a "sustainable" investing firm established in 2004 by David Blood and U.S. Vice President AI Gore. Places students in the position of David Lowish, director of global industrials, who must decide whether to recommend... View Details
Keywords: Martha Lagace
  • 10 May 2011
  • First Look

First Look: May 10

but also that NEAD chains produced more transplants for highly sensitized and blood type O recipients. Read the paper: http://kuznets.fas.harvard.edu/~aroth/papers/Nonsimultaneous%20Chains%20AJT%202011.pdf Female Empowerment: Impact of a... View Details
Keywords: Sean Silverthorne
  • 06 Jun 2017
  • First Look

First Look at New Research and Ideas: June 6, 2017

Pharmacyclics is a biotechnology company that had received FDA approval in late 2013 for its flagship asset Imbrivica (ibrutinib), a biologic treatment for chronic lymphocytic leukemia and two other even rarer blood malignancies. Entering... View Details
Keywords: Sean Silverthorne

Are you looking for?

→Search All HBS Web